Stemtech Corporation (STEK)
OTC Markets OTCID
Fundamentals
Valuation and ratings
Stemtech Corporation trades at USD0.00. We do not hold enough of the inputs to run a discounted cash flow on this company, so we publish no fair value for it rather than a number we would not defend.
About Stemtech Corporation
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its products under the RCM System, stemrelease3, and Stemflo MigraStem brands; oral health care under the OraStem brand; and rapid renew stem cell peptide night cream under the Collect One brand name, as well as Cellect One shield hypochlorous acid skin care products. It sells products through independent distributors. Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.
The full research page for STEK, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.